Find Reports
Select Report Type
Reimbursement Review
Displaying 1026 - 1050 of 1258
Please scroll or swipe to the right to view the full content.
| Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|
| Semglee | insulin glargine | Diabetes mellitus, Type 1 & 2 | Withdrawn | SE0589-000 | ||||
| TBC | filgrastim | Cancelled | SE0596-000 | |||||
| Orilissa | elagolix | Moderate to severe pain associated with endometriosis | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0011-000 | |||
| Keytruda | pembrolizumab | Gastrointestinal Cancer | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0012-000 | |||
| Latuda | lurasidone | Bipolar I disorder | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0010-000 | |||
| Kineret | anakinra | Still's disease | Withdrawn | SR0662-000 | ||||
| Tysabri | natalizumab | Multiple Sclerosis, relapsing-remitting | Withdrawn | SR0687-000 | ||||
| TBC | abaloparatide | Osteoporosis, postmenopausal women | Withdrawn | SR0744-000 | ||||
| Breo Ellipta | fluticasone furoate/vilanterol | Asthma | Withdrawn | SR0568-000 | ||||
| TBD | Cabozantinib | Withdrawn | PC0123-000 | |||||
| Ikervis | cyclosporine | keratitis, severe | Withdrawn | SR0518-000 | ||||
| Breo Ellipta | fluticasone furoate/vilanterol | COPD | Withdrawn | SR0524-000 | ||||
| Iluvien | fluocinolone acetonide | Diabetic macular edema (DME) | Withdrawn | SR0549-000 | ||||
| Erbitux | Cetuximab | Cancelled | PC0128-000 | |||||
| Lapelga | Pegfilgrastim | Febrile neutropenia | N/A | Complete | SE0555-000 | |||
| Kynmobi | apomorphine hydrochloride | Parkinson’s Disease | Withdrawn | SR0604-000 | ||||
| TBD | Rituximab | Cancelled | PC0180-000 | |||||
| Translarna | ataluren | Cancelled | SR0607-000 | |||||
| Bosulif (RFA) | Bosutinib | Chronic Myeloid Leukemia | N/A | Complete | PA0002-000 | |||
| TBD | Trastuzumab | Cancelled | PC0160-000 | |||||
| Truxima | Rituximab | Cancelled | PC0184-000 | |||||
| Ogivri | Trastuzumab | Withdrawn | PC0169-000 | |||||
| Zytiga | Abiraterone | Withdrawn | PC0166-000 | |||||
| TBC | halobetasol propionate and tazarotene | Psoriasis, moderate to severe plaque | Withdrawn | SR0600-000 | ||||
| TBD | Bevacizumab | Cancelled | PC0178-000 |
Health Technology Review
Displaying 576 - 589 of 589
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 40 of 40
View All Reports
Displaying 1026 - 1050 of 2093
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Rituximab to Treat Primary Membranous Nephropathy | Health Technology Review | Health Technology Assessment | Completed | HT0032-000 - HS0001-000 | |||
| ofatumumab | Reimbursement Review | Complete | SR0657-000 | ||||
| Tuberculosis Stigma and Racism, Colonialism, and Migration: A Rapid Qualitative Review | Health Technology Review | Summary with Critical Appraisal | Completed | RC1350-000 | |||
| Rituximab for the Treatment of Myasthenia Gravis: A 2021 Update | Health Technology Review | Rapid Review | RC1337-000 | ||||
| Isatuximab (Sarclisa) for Multiple Myeloma - Details | Reimbursement Review | Complete | PC0220-000 | ||||
| Urethral Inserts for the Management of Adult Male Urinary Incontinence | Health Technology Review | Rapid Review | Completed | RC1355-000 | |||
| Avelumab (Bavencio) for Urothelial Carcinoma - Details | Reimbursement Review | Complete | PC0225-000 | ||||
| Pharmacological Interventions for Vaping Cessation | Health Technology Review | Summary with Critical Appraisal | Completed | RC1357-000 | |||
| Bupropion for Treatment Resistant Depression | Health Technology Review | Summary with Critical Appraisal | Completed | RC1351-000 | |||
| Models of Care for Chronic Pain: An Environmental Scan | Health Technology Review | Environmental Scan | Completed | ES0350-000 | |||
| Lenses and Spectacles to Prevent Myopia Worsening in Children | Health Technology Review | Summary with Critical Appraisal | RC1349-000 | ||||
| Interferon Gamma Release Assay for the Identification of Latent Tuberculosis Infection in Rural and Remote Settings | Health Technology Review | Summary with Critical Appraisal | Completed | RC1341-000 | |||
| Flash Glucose Monitoring Systems in Pediatric Populations with Diabetes | Health Technology Review | Summary with Critical Appraisal | Completed | RC1354-000 | |||
| Levetiracetam | Reimbursement Review | Complete | SR0653-000 | ||||
| COVID-19 Impact on Intimate Partner Violence and Child Maltreatment | Health Technology Review | CI0145-000 | |||||
| Point-of-Care Testing of International Normalized Ratios for People on Oral Anticoagulants: A Rapid Qualitative Review | Health Technology Review | Summary with Critical Appraisal | Completed | RC1334-000 | |||
| sacubitril/valsartan | Reimbursement Review | Complete | SR0644-000 | ||||
| fremanezumab | Reimbursement Review | Complete | SR0641-000 | ||||
| CADTH Pharmaceutical Reviews Update — Issue 22 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Chronic Lymphocytic Leukemia | Reimbursement Review | Provisional Funding Algorithm | Completed | PH0004-000 | |||
| tafamidis | Reimbursement Review | Complete | SR0625-000 | ||||
| Nivolumab-Ipilimumab for Non-Small Cell Lung Cancer - Details | Reimbursement Review | Complete | PC0218-000 | ||||
| Treatment Sequences of Androgen Receptor Targeted Agents for Patients with Prostate Cancer | Health Technology Review | Summary with Critical Appraisal | Completed | RC1347-000 | |||
| cyclosporine | Reimbursement Review | Complete | SR0615-000 | ||||
| Remote Monitoring Programs for Cardiac Conditions in Canada | Health Technology Review | Environmental Scan | Completed | ES0345-000 |